California BanCorp \ CA — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that California BanCorp \ CA filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $63.06M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $5.43M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $25.91M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $16.11M | Mar 15, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.29M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $50.29M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $33.10M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $13.35M | Mar 15, 2024 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $346.0K | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $552.0K | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $302.0K | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $1.08M | Mar 15, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.03B | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $4.03B | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $2.36B | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $2.28B | Mar 15, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.46B | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $3.52B | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $2.07B | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $2.02B | Mar 15, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $576.59M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $511.84M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $288.15M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $260.36M | Apr 1, 2025 |
| FY2023 | Dec 31, 2021 | $246.53M | Mar 15, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $110.93M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $111.79M | Mar 13, 2026 |
| FY2025 | Dec 31, 2023 | $37.80M | Mar 13, 2026 |
| FY2024 | Dec 31, 2022 | $37.80M | Apr 1, 2025 |
| FY2023 | Dec 31, 2021 | $36.78M | Mar 15, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $135.81M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $76.01M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $70.58M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $48.52M | Mar 15, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $399.91M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $388.16M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $86.79M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $86.76M | Mar 15, 2024 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.83M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $69.73M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | $102.87M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $67.77M | Mar 15, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 15, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 15, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 32.42M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | 32.27M | Mar 13, 2026 |
| FY2024 | Dec 31, 2023 | 18.37M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | 17.94M | Mar 15, 2024 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.25M | Mar 13, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 13, 2026 |